Celltrion Pharm, Inc.

KOSDAQ 068760.KQ

Celltrion Pharm, Inc. Inventory for the year ending December 31, 2023: USD 77.12 M

Celltrion Pharm, Inc. Inventory is USD 77.12 M for the year ending December 31, 2023, a 41.12% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Celltrion Pharm, Inc. Inventory for the year ending December 31, 2022 was USD 54.65 M, a 2.20% change year over year.
Celltrion Pharm, Inc. Inventory for the year ending December 31, 2021 was USD 53.47 M, a 5.88% change year over year.
Celltrion Pharm, Inc. Inventory for the year ending December 31, 2020 was USD 50.50 M, a 76.99% change year over year.
Celltrion Pharm, Inc. Inventory for the year ending December 31, 2019 was USD 28.53 M, a -24.04% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

KOSDAQ: 068760.KQ

Celltrion Pharm, Inc.

CEO	Jung-su Seo
IPO Date	Feb. 3, 2006
Location	South Korea
Headquarters	82, 2sandan-ro
Employees	888
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.

Key trends

Past 5 years